Angela Lamarca, Lead of NET HPB and NET Medical Oncologist an Fundación Jiménez Diaz University Hospital. Chair of ESMO Communication Commitee. Lead of EORTC NET WG shared a post on X:
“Waiting for two abstracts to be presented the whole AACR, AACR26, this is one of them.
Just presented, Daraxonrasib in mKRAS PDAC by Eileen M O’Reilly.
Monotherapy in the First Line
- 38 pts
- ORR 47%
- Time on tto 7.7m
- PFS immature
Ongoing Phase III 303 (Dara vs GemNab+/-Dara).
Example of the excitement around it… Well done Eileen M O’Reilly answering all the questions! Non-stop! Could not even say hi in person.”
Other articles about AACR on OncoDaily.
